Program Management Archives - Juvena Therapeutics

Matt Gross

Matt Gross brings over 20 years of broad biotech experience in Business Development, Alliance Management and Drug Development. Most recently he served as Vice President of Business Development at Rapafusyn Pharmaceuticals Inc., where he closed a multi-target Research Collaboration with a top tier Pharma company. Prior to Rapafusyn, he served as VP of Business Development at Calithera Biosciences where he led BD, alliance management, and strategic planning functions. During his time at Calithera he was responsible for closing multiple transactions including an acquisition of clinical stage oncology assets from Takeda. Prior to his role in Business Development, he served as the Director of Pharmacology at Calithera.

Mr. Gross has a diverse scientific background in pharmacology, toxicology and translational medicine. Prior to Calithera, he served as Scientist II at Adamas Pharmaceuticals. Mr. Gross has held scientific positions with increasing responsibility at Adamas Pharmaceuticals, Avigen Inc., Xoma Corporation and GeneSoft Inc. He received his Bachelor of Science in Biological Sciences from University of California, Santa Barbara.

Learn more about Matt

Dasom (Christine) Yoo, PhD

Christine Yoo, PhD, joined Juvena Therapeutics in May 2025 as Senior Corporate Development Manager. Prior to joining Juvena, she was a Senior Associate at Propel Bio Partners, a life sciences venture capital firm. As the fund’s first hire, Christine played a key role in building internal operations and led due diligence efforts on private therapeutics and biotech companies from Seed through Series B stages.
Before her time in venture capital, Christine served as a Business Development Manager at the Fred Hutchinson Cancer Center in Seattle, where she supported strategic partnerships and commercialization initiatives.

Christine earned both her B.S. and Ph.D. in Bioengineering from the University of Washington, where her research focused on cardiac regeneration using stem cell-derived cardiomyocytes. Outside of work, she enjoys exploring the outdoors with her husband and their two golden retrievers.

Learn More about Christine